Table 1. Clinic-pathological features of 62 patients examined for hormones receptor expression.
| CLINIC-PATHOLOGICAL FEATURES OF 62 PATIENTS WITH NSCLC | |
|---|---|
| GENDER | N. |
| MALES | 36 (58%) |
| FEMALES | 26 (42%) |
| AGE | |
| MEDIAN [RANGE] | 67,5 MONTHS (34-85) |
| STAGE OF DISEASE AT INITIAL DIAGNOSIS | |
| I | 4 (6,4%) |
| IIA | 4 (6,4%) |
| IIB | 3(4,8%) |
| IIIA | 10 (16,1%) |
| IIIB | 6 (9,7%) |
| IV | 35 (56,5%) |
| IIIB/IV | 41 (66,1%) |
| SMOKING HABIT | |
| YES | 37 (59,7%) |
| NO | 21 (33,9%) |
| UNKNOWN | 4 (6,4%) |
| PERFORMANCE STATUS (ECOG) | |
| 0 | 35 (56,5%) |
| 1 | 25 (40,3%) |
| 2 | 2 (3,2%) |
| SITE OF METASTASIS | |
| BONE | 22 (35,4%) |
| CNS | 9 (14,5%) |
| LYMPH-NODES | 8 (12,9%) |
| PLEURA | 14 (22,6%) |
| LIVER | 6 (9,7%) |
| LUNG | 22 (35,4%) |
| ADRENAL GLAND | 2 (3,2%) |
| OTHER | 412 (66,13,2%) |
| DEATH | |
| YES | 44 (71%) |
| NO | 18 (29%) |